Policy

A ScienceSoft report finds technology and demand are in place, but regulatory uncertainty looms.

Food, chemicals, behavior, medicine all play a role in helping or hurting Americans’ health, according to new MAHA report, but farmers say there’s junk science behind some claims.

AAFP board chair details potential effects in critique of federal spending plan.

Responses focus on health care as House approves One Big Beautiful Bill federal spending legislation.

HHS has made changes, but lawmakers want prior auth procedures codified in law.

As Trump and Congress debate the Big Beautiful Bill, public health, medical research, and Medicaid could ‘Make America Healthy Again’ — if the nation pays for them.

HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.

An expert physician panel discusses how vaccine policy has gone wrong under the Trump administration, why misinformation has flourished and what individual physicians can do to win back patient trust.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

A new study in JAMA Health Forum finds women primary care physicians earn more under value-based models — while delivering better outcomes and fewer hospital visits.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

House Budget Committee takes up debate and AMGA publishes projections due to Medicaid cuts in One Big Beautiful Bill Act.

Trump administration tallies ‘staggering cost’ of opioid epidemic as lawmakers ponder budget.

Congressional committees review spending with Health and Human Services Department leader.

Public health experts react to HHS Secretary Robert F. Kennedy’s testimony of budget in House of Representatives.

Digital health leaders unite in the Remote Monitoring Leadership Council to promote remote patient monitoring and advocate for supportive health policies.

Robert F. Kennedy Jr. testifies about HHS budget before House Appropriations Committee.

House committee begins deliberations on federal budget reconciliation bill, which includes Medicaid.

As use of artificial intelligence grows rapidly in health care, the American Medical Association brought together an expert panel to highlight policy changes, transparency concerns and implications for physician practices.

Energy & Commerce Chair Rep. Brett Guthrie spells out need for changes to Medicaid.

Three House committee leaders speak out on spending plan up for debate today.

Expert physicians discuss the urgent need to rebuild trust in vaccines amid rising skepticism and misinformation during the Trump administration, emphasizing the role of physicians in public health.

Republican committee chair says Medicaid claims are unfounded, but advocacy groups, Democrats are predicting dire consequences.